• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves.糖胺聚糖稳定化对生物人工心脏瓣膜组织屈曲的影响。
Biomaterials. 2008 Apr;29(11):1645-53. doi: 10.1016/j.biomaterials.2007.12.009. Epub 2008 Jan 15.
2
Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves.新霉素可防止生物人工心脏瓣膜中酶介导的糖胺聚糖降解。
Biomaterials. 2007 Jun;28(18):2861-8. doi: 10.1016/j.biomaterials.2007.02.017. Epub 2007 Mar 13.
3
Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.猪主动脉心脏瓣膜中的糖胺聚糖降解酶:对生物人工心脏瓣膜退变的影响
J Heart Valve Dis. 2003 Mar;12(2):217-25.
4
Periodate-mediated glycosaminoglycan stabilization in bioprosthetic heart valves.高碘酸盐介导的生物人工心脏瓣膜中糖胺聚糖的稳定化
J Biomed Mater Res. 2001 Sep 15;56(4):478-86. doi: 10.1002/1097-4636(20010915)56:4<478::aid-jbm1119>3.0.co;2-c.
5
Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves.新霉素固定后乙醇预处理可减少生物瓣的皱缩和钙化。
J Biomed Mater Res B Appl Biomater. 2010 Jan;92(1):168-77. doi: 10.1002/jbm.b.31503.
6
Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves.猪生物人工心脏瓣膜中糖胺聚糖的稳定性与功能
Biomaterials. 2006 Mar;27(8):1507-18. doi: 10.1016/j.biomaterials.2005.08.003. Epub 2005 Sep 6.
7
Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study.生物人工心脏瓣膜瓣叶和壁组织的退变在组织制备过程中就已开始:一项超微结构研究。
J Heart Valve Dis. 2003 Mar;12(2):226-34.
8
Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves.采用新霉素和碳二亚胺交联代替戊二醛以提高生物心脏瓣膜的耐久性。
J Biomater Appl. 2013 May;27(8):948-60. doi: 10.1177/0885328211430542. Epub 2011 Dec 29.
9
Neomycin enhances extracellular matrix stability of glutaraldehyde crosslinked bioprosthetic heart valves.新霉素增强戊二醛交联生物瓣的细胞外基质稳定性。
J Biomed Mater Res B Appl Biomater. 2011 Nov;99(2):217-29. doi: 10.1002/jbm.b.31889. Epub 2011 Jun 28.
10
Enzyme-oxidative-polymerization method for improving glycosaminoglycans stability and reducing calcification in bioprosthetic heart valves.酶氧化聚合方法提高生物心脏瓣膜中糖胺聚糖的稳定性和减少钙化。
Biomed Mater. 2019 Feb 8;14(2):025012. doi: 10.1088/1748-605X/aafd7c.

引用本文的文献

1
Swim bladder-derived biomaterials: structures, compositions, properties, modifications, and biomedical applications.鱼鳔衍生生物材料:结构、组成、性质、改性及生物医学应用。
J Nanobiotechnology. 2024 Apr 17;22(1):186. doi: 10.1186/s12951-024-02449-w.
2
The hybrid crosslinking method improved the stability and anti-calcification properties of the bioprosthetic heart valves.混合交联方法提高了生物人工心脏瓣膜的稳定性和抗钙化性能。
Front Bioeng Biotechnol. 2022 Sep 9;10:1008664. doi: 10.3389/fbioe.2022.1008664. eCollection 2022.
3
A Novel Crosslinking Method for Improving the Anti-Calcification Ability and Extracellular Matrix Stability in Transcatheter Heart Valves.一种用于提高经导管心脏瓣膜抗钙化能力和细胞外基质稳定性的新型交联方法。
Front Bioeng Biotechnol. 2022 Jul 12;10:909771. doi: 10.3389/fbioe.2022.909771. eCollection 2022.
4
Bioprosthetic Aortic Valve Degeneration: a Review from a Basic Science Perspective.生物瓣主动脉瓣退行性变:从基础科学角度的综述。
Braz J Cardiovasc Surg. 2022 May 2;37(2):239-250. doi: 10.21470/1678-9741-2020-0635.
5
An investigation of the glycosaminoglycan contribution to biaxial mechanical behaviours of porcine atrioventricular heart valve leaflets.探讨氨基葡聚糖对猪房室瓣双轴力学行为的贡献。
J R Soc Interface. 2019 Jul 26;16(156):20190069. doi: 10.1098/rsif.2019.0069. Epub 2019 Jul 3.
6
Mechanics of the Tricuspid Valve-From Clinical Diagnosis/Treatment, In-Vivo and In-Vitro Investigations, to Patient-Specific Biomechanical Modeling.三尖瓣的力学——从临床诊断/治疗、体内和体外研究到患者特异性生物力学建模
Bioengineering (Basel). 2019 May 22;6(2):47. doi: 10.3390/bioengineering6020047.
7
Exogenous hyaluronic acid and chondroitin sulfate crosslinking treatment for increasing the amount and stability of glycosaminoglycans in bioprosthetic heart valves.外源性透明质酸和硫酸软骨素交联处理增加生物瓣心脏瓣膜中糖胺聚糖的含量和稳定性。
J Mater Sci Mater Med. 2019 Mar 6;30(3):38. doi: 10.1007/s10856-019-6237-7.
8
Design, Analysis and Testing of a Novel Mitral Valve for Transcatheter Implantation.用于经导管植入的新型二尖瓣的设计、分析与测试
Ann Biomed Eng. 2017 Aug;45(8):1852-1864. doi: 10.1007/s10439-017-1828-2. Epub 2017 Apr 3.
9
A novel crosslinking method for improved tear resistance and biocompatibility of tissue based biomaterials.一种用于提高基于组织的生物材料的抗撕裂性和生物相容性的新型交联方法。
Biomaterials. 2015 Oct;66:83-91. doi: 10.1016/j.biomaterials.2015.07.011. Epub 2015 Jul 14.
10
Neomycin and pentagalloyl glucose enhanced cross-linking for elastin and glycosaminoglycans preservation in bioprosthetic heart valves.新型霉素和五倍子酰葡萄糖增强交联以保存生物人工心脏瓣膜中的弹性蛋白和糖胺聚糖。
J Biomater Appl. 2014 Jan;28(5):757-66. doi: 10.1177/0885328213479047.

本文引用的文献

1
Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves.新霉素可防止生物人工心脏瓣膜中酶介导的糖胺聚糖降解。
Biomaterials. 2007 Jun;28(18):2861-8. doi: 10.1016/j.biomaterials.2007.02.017. Epub 2007 Mar 13.
2
Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization.靶向糖胺聚糖的固定以改善生物人工心脏瓣膜的稳定性。
Biomaterials. 2007 Jan;28(3):496-503. doi: 10.1016/j.biomaterials.2006.09.005. Epub 2006 Oct 9.
3
The flexural rigidity of the aortic valve leaflet in the commissural region.主动脉瓣叶在瓣叶联合区的抗弯刚度。
J Biomech. 2006;39(16):2966-73. doi: 10.1016/j.jbiomech.2005.10.026. Epub 2005 Dec 19.
4
Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves.猪生物人工心脏瓣膜中糖胺聚糖的稳定性与功能
Biomaterials. 2006 Mar;27(8):1507-18. doi: 10.1016/j.biomaterials.2005.08.003. Epub 2005 Sep 6.
5
Sulphated oligosaccharides as inhibitors of hyaluronidases from bovine testis, bee venom and Streptococcus agalactiae.硫酸化寡糖作为牛睾丸、蜂毒和无乳链球菌透明质酸酶的抑制剂
Planta Med. 2005 Aug;71(8):727-32. doi: 10.1055/s-2005-871255.
6
Reduced calcification of bioprostheses, cross-linked via an improved carbodiimide based method.通过改进的基于碳二亚胺的方法交联的生物假体钙化减少。
Biomaterials. 2004 Nov;25(24):5523-30. doi: 10.1016/j.biomaterials.2003.12.054.
7
Biaxial mechanical response of bioprosthetic heart valve biomaterials to high in-plane shear.生物人工心脏瓣膜生物材料对高面内剪切力的双轴力学响应。
J Biomech Eng. 2003 Jun;125(3):372-80. doi: 10.1115/1.1572518.
8
Loss of chondroitin 6-sulfate and hyaluronan from failed porcine bioprosthetic valves.猪生物人工心脏瓣膜失效后硫酸软骨素 6 - 硫酸酯和透明质酸的流失。
J Biomed Mater Res A. 2003 May 1;65(2):251-9. doi: 10.1002/jbm.a.10475.
9
Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.猪主动脉心脏瓣膜中的糖胺聚糖降解酶:对生物人工心脏瓣膜退变的影响
J Heart Valve Dis. 2003 Mar;12(2):217-25.
10
A multivalent assay to detect glycosaminoglycan, protein, collagen, RNA, and DNA content in milligram samples of cartilage or hydrogel-based repair cartilage.一种用于检测毫克级软骨样本或水凝胶基修复软骨中糖胺聚糖、蛋白质、胶原蛋白、RNA和DNA含量的多价检测方法。
Anal Biochem. 2002 Jan 1;300(1):1-10. doi: 10.1006/abio.2001.5436.

糖胺聚糖稳定化对生物人工心脏瓣膜组织屈曲的影响。

The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves.

作者信息

Shah Sagar R, Vyavahare Naren R

机构信息

Cardiovascular Implant Research Laboratory, Department of Bioengineering, Clemson University, 401 Rhodes Engineering Research Center, Clemson, SC 29634, USA.

出版信息

Biomaterials. 2008 Apr;29(11):1645-53. doi: 10.1016/j.biomaterials.2007.12.009. Epub 2008 Jan 15.

DOI:10.1016/j.biomaterials.2007.12.009
PMID:18199477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2268977/
Abstract

Bioprosthetic valves are used in thousands of heart valve replacement surgeries. Existing glutaraldehyde-crosslinked bioprosthetic valves fail due to either calcification or degeneration. Glutaraldehyde crosslinking does not stabilize valvular glycosaminoglycans (GAGs). GAGs, predominantly present in the medial spongiosa layer of native heart valve cusps, play an important role in regulating physico-mechanical behavior of the native cuspal tissue during dynamic motion. The primary objective of this study was to identify the role of cuspal GAGs in valve tissue buckling. Glutaraldehyde-crosslinked cusps showed extensive buckling compared to fresh, native cusps. Removal of GAGs by treatment with GAG-degrading enzymes led to a marked increase in buckling behavior in glutaraldehyde-crosslinked cusps. We demonstrate that the retention of valvular GAGs by carbodiimide crosslinking together with chemical attachment of neomycin trisulfate (a hyaluronidase inhibitor), prior to glutaraldehyde crosslinking, reduces the extent of buckling in bioprosthetic heart valves. Furthermore, following exposure to GAG-digestive enzymes, neomycin-trisulfate-bound cusps experienced no alterations in buckling behavior. Such moderate buckling patterns mimicked that of fresh, untreated cusps subjected to similar bending curvatures. Thus, GAG stabilization may subsequently improve the durability of these bioprostheses.

摘要

生物人工心脏瓣膜被应用于数千例心脏瓣膜置换手术中。现有的戊二醛交联生物人工心脏瓣膜会因钙化或退化而失效。戊二醛交联无法稳定瓣膜糖胺聚糖(GAGs)。GAGs主要存在于天然心脏瓣膜尖的内侧海绵层,在动态运动过程中对调节天然瓣膜尖组织的物理力学行为起着重要作用。本研究的主要目的是确定瓣膜尖GAGs在瓣膜组织屈曲中的作用。与新鲜的天然瓣膜尖相比,戊二醛交联的瓣膜尖表现出广泛的屈曲。用GAG降解酶处理去除GAGs会导致戊二醛交联瓣膜尖的屈曲行为显著增加。我们证明,在戊二醛交联之前,通过碳二亚胺交联保留瓣膜GAGs并化学连接新霉素三硫酸盐(一种透明质酸酶抑制剂),可减少生物人工心脏瓣膜的屈曲程度。此外,在暴露于GAG消化酶后,结合新霉素三硫酸盐的瓣膜尖的屈曲行为没有改变。这种适度的屈曲模式类似于新鲜的、未处理的瓣膜尖在类似弯曲曲率下的屈曲模式。因此,GAG的稳定化可能随后提高这些生物假体的耐久性。